The first child to undergo CAR T-cell therapy at CHOP for leukemia is now a student at Penn

Tags: cancer treatment, CAR T-cell therapy, CHOP, Emily Whitehead, gene therapy, immunotherapy, leukemia, long-term remission, medical breakthrough, pediatric cancer, personalized medicine, University of Pennsylvania

The article highlights the success of Emily Whitehead, the first child to undergo CAR T-cell therapy at CHOP for leukemia, who is now cancer-free more than a decade later, demonstrating the transformative potential of this innovative immunotherapy treatment.